Literature DB >> 24055326

Observational research--opportunities and limitations.

Edward J Boyko1.   

Abstract

Medical research continues to progress in its ability to identify treatments and characteristics associated with benefits and adverse outcomes. The principal engine for the evaluation of treatment efficacy is the randomized controlled trial (RCT). Due to the cost and other considerations, RCTs cannot address all clinically important decisions. Observational research often is used to address issues not addressed or not addressable by RCTs. This article provides an overview of the benefits and limitations of observational research to serve as a guide to the interpretation of this category of research designs in diabetes investigations. The potential for bias is higher in observational research but there are design and analysis features that can address these concerns although not completely eliminate them. Pharmacoepidemiologic research may provide important information regarding relative safety and effectiveness of diabetes pharmaceuticals. Such research must effectively address the important issue of confounding by indication in order to produce clinically meaningful results. Other methods such as instrumental variable analysis are being employed to enable stronger causal inference but these methods also require fulfillment of several key assumptions that may or may not be realistic. Nearly all clinical decisions involve probabilistic reasoning and confronting uncertainly, so a realistic goal for observational research may not be the high standard set by RCTs but instead the level of certainty needed to influence a diagnostic or treatment decision.
© 2013.

Entities:  

Keywords:  Bias; Causal Inference; Confounding; Epidemiology; Pharmacoepidemiology; Randomized Controlled Trial

Mesh:

Year:  2013        PMID: 24055326      PMCID: PMC3818421          DOI: 10.1016/j.jdiacomp.2013.07.007

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  50 in total

1.  Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative.

Authors:  Lesley F Tinker; Gloria E Sarto; Barbara V Howard; Ying Huang; Marian L Neuhouser; Yasmin Mossavar-Rahmani; Jeannette M Beasley; Karen L Margolis; Charles B Eaton; Lawrence S Phillips; Ross L Prentice
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

2.  Instruments for causal inference: an epidemiologist's dream?

Authors:  Miguel A Hernán; James M Robins
Journal:  Epidemiology       Date:  2006-07       Impact factor: 4.822

3.  Big Data: Large-Scale Historical Infrastructure from the Minnesota Population Center.

Authors:  Matthew Sobek; Lara Cleveland; Sarah Flood; Patricia Kelly Hall; Miriam L King; Steven Ruggles; Matthew Schroeder
Journal:  Hist Methods       Date:  2011-01-01

4.  The threshold approach to clinical decision making.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1980-05-15       Impact factor: 91.245

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Authors:  Ross L Prentice; Robert Langer; Marcia L Stefanick; Barbara V Howard; Mary Pettinger; Garnet Anderson; David Barad; J David Curb; Jane Kotchen; Lewis Kuller; Marian Limacher; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2005-07-20       Impact factor: 4.897

7.  Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.

Authors:  Christianne L Roumie; Adriana M Hung; Robert A Greevy; Carlos G Grijalva; Xulei Liu; Harvey J Murff; Tom A Elasy; Marie R Griffin
Journal:  Ann Intern Med       Date:  2012-11-06       Impact factor: 25.391

Review 8.  Chrysotile, tremolite, and malignant mesothelioma in man.

Authors:  A Churg
Journal:  Chest       Date:  1988-03       Impact factor: 9.410

9.  Blocked randomization with randomly selected block sizes.

Authors:  Jimmy Efird
Journal:  Int J Environ Res Public Health       Date:  2010-12-23       Impact factor: 3.390

10.  The missed lessons of Sir Austin Bradford Hill.

Authors:  Carl V Phillips; Karen J Goodman
Journal:  Epidemiol Perspect Innov       Date:  2004-10-04
View more
  43 in total

Review 1.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

2.  The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes.

Authors:  Cornelia M Ulrich; Biljana Gigic; Graham A Colditz; Jane C Figueiredo; William M Grady; Christopher I Li; David Shibata; Erin M Siegel; Adetunji T Toriola; Alexis Ulrich; Jürgen Böhm; Jennifer Ose; Richard Viskochil; Martin Schneider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-12-06       Impact factor: 4.254

3.  Newborn blood gas derangements of children born extremely preterm and neurocognitive dysfunctions at age 10 years.

Authors:  Alan Leviton; Elizabeth N Allred; Robert M Joseph; T Michael O'Shea; Karl C K Kuban
Journal:  Respir Physiol Neurobiol       Date:  2017-04-07       Impact factor: 1.931

4.  Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis.

Authors:  Yuanyuan Wang; Job F M van Boven; Jens H J Bos; Catharina C M Schuiling-Veninga; H Marike Boezen; Bob Wilffert; Eelko Hak
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-09-09       Impact factor: 2.732

5.  Utilization of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacoepidemiological Studies: A Systematic Review on Antiarrhythmic and Glucose-Lowering Medicines.

Authors:  Soroush Mohammadi Jouabadi; Mitra Nekouei Shahraki; Payam Peymani; Bruno H Stricker; Fariba Ahmadizar
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

6.  Effect on Patients' Outcomes of a Change to Biosimilar Filgrastim Product in Autologous Stem Cell Mobilization.

Authors:  Jennifer Fenna; Micheal Guirguis; Caroline Ibrahim; Neeta Shirvaikar; Irwindeep Sandhu; Sunita Ghosh; Melissa Jenkins
Journal:  Can J Hosp Pharm       Date:  2021-04-01

7.  Age at first birth and lung cancer: a two-sample Mendelian randomization study.

Authors:  Haoxin Peng; Xiangrong Wu; Yaokai Wen; Xiaoqin Du; Caichen Li; Hengrui Liang; Jinsheng Lin; Jun Liu; Fan Ge; Zhenyu Huo; Jianxing He; Wenhua Liang
Journal:  Transl Lung Cancer Res       Date:  2021-04

8.  Mendelian randomization suggests that head circumference, but not birth weight and length, associates with intelligence.

Authors:  Li Qian; Fengjie Gao; Bin Yan; Lihong Yang; Wei Wang; Ling Bai; Xiancang Ma; Jian Yang
Journal:  Brain Behav       Date:  2021-05-10       Impact factor: 2.708

Review 9.  Impact of Adjuvant Use of Midodrine to Intravenous Vasopressors: A Systematic Review and Meta-Analysis.

Authors:  Ahmad Al-Abdouh; Sadam Haddadin; Atul Matta; Ahmad Jabri; Mahmoud Barbarawi; Waiel Abusnina; Qais Radideh; Mohammed Mhanna; Dante A Suffredini; Erin D Michos
Journal:  Crit Care Res Pract       Date:  2021-05-15

10.  Causal Inference Between Chronic Periodontitis and Chronic Kidney Disease: A Bidirectional Mendelian Randomization Analysis in a European Population.

Authors:  Jie Yang; Tianyi Chen; Yahong Zhu; Mingxia Bai; Xingang Li
Journal:  Front Genet       Date:  2021-06-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.